ArticleThe journal of allergy and clinical immunology. Global2026

Real-world outcomes and corticosteroid sparing with mepolizumab for EGPA or HES.

Michael E Wechsler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.